Grande Alicia's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Aug 30, 2022
- Accession no.
- 0001161697-22-000425
- Filed
- Aug 30, 2022
- Trade date
- Aug 26-29, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $969.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grande AliciaCIK 0001402652 | Officer (VP, Treasurer and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 | Common Stock, par value $0.001 per share | SSaleDisposed | −11,095 | $14.40 | −$159,768 | 464,442 | Direct | |
| Aug 29, 2022 | Common Stock, par value $0.001 per share | SSaleDisposed | −20,000 | $14.14 | −$282,800 | 444,442 | Direct | |
| Aug 29, 2022 | Common Stock, par value $0.001 per share | SSaleDisposed | −20,000 | $14.20 | −$284,000 | 424,442 | Direct | |
| Aug 29, 2022 | Common Stock, par value $0.001 per share | SSaleDisposed | −17,000 | $14.28 | −$242,760 | 407,442 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.